Roundup Cancer Lawsuit News

Environmental Activists Challenge the EPA's Glyphosate Risk Assessment

Groups representing a plaintiff who recently sued Monsanto claim that the EPA's credibility was compromised and the agency ignored vital studies that show glyphosate causes cancer

Monday, April 6, 2020 - The Environmental Working Group (EWG) has challenged the appeal of Monsanto trying to overturn an $80 million jury award given go California farmer Edwin Hardeman. Hardeman successfully sued Monsanto in March of 2018, months before the company was acquired by German conglomerate Bayer. The EWG claims that Monsanto's argument relies on an EPA risk assessment that "ignored dozens of independent studies, many of which showed strong evidence that the herbicide causes cancer in people," according to EWG. Also, EWG wrote that the EPA's risk assessment used to challenge the Hardeman verdict was unreliable and heavily influenced by Monsanto, and that "the EPA largely depended on studies paid for and conducted by Monsanto, while completely ignoring a wide body of independent research that show connections between cancer and exposure to glyphosate and Roundup." The EWG claims that the EPA ignored many of the studies that the International Agency for Cancer Research used to conclude that glyphosate is "probably carcinogenic." Attorneys point to internal emails that show collusion between the EPA and Monsanto which was trying to persuade the EPA to block an upcoming glyphosate cancer risk assessment by the Agency for Toxic Chemicals and Disease Registry. In April 2019 the EPA confirmed the IARC's glyphosate cancer risk stance without examining occupational risks of using glyphosate and instead focused only on glyphosate in one's diet. Monsanto Roundup herbicide cancer lawsuits are handled by national attorneys and offer a free consultation.

It is widely believed that occupational users of Roundup herbicide such as maintenance workers, groundskeepers, landscapers, and farmers have the highest risk of developing cancer from repeatedly making direct skin contact with the glyphosate causing irritation that leads to non-Hodgkin's lymphoma, a deadly form of cancer of the lymph nodes. Roundup contains a chemical that causes it to stick to plants and become absorbed more effectively and the same is thought to occur on human skin.

Such was the case in the first of three California trials claiming Roundup caused their skin cancer. A California jury found Monsanto guilty of failing to warn users to wear protective waterproof clothing when applying the weedkiller and awarded DeWayne Lee Johnson $289 million, alerting the public and igniting an estimated 80,000 similar lawsuits against Monsanto and their parent company Bayer.

Further trials against Bayer/Monsanto have been put on hold as the company tries to work out a settlement that is thought to cost the company between $10 and $20 billion. That amount can be added to the staggering losses Monsanto will absorb as a result of many European nations such as France, The Netherlands, Germany, and Belgium all either banning glyphosate or phasing out using the weedkiller over years. Glyphosates's license to do business in Europe will also be coming up for renewal and given the current sentiment could be canceled or modified. Without glyphosate, Monsanto's multi-billion-dollar genetically modified seed busing is in jeopardy, making Bayer's $63 billion investment to buy the company look foolish.

More Recent Roundup Cancer Lawsuit News:

Lawyers for Roundup Cancer Lawsuits

Attorneys handling Roundup cancer lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Roundup cancer lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Roundup cancer lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.